Kezar Life Sciences Inc (KZR) — Financial Flexibility Index
Kezar Life Sciences Inc (KZR) has a Financial Flexibility Index of -1.82x as of December 2025. Free cash flow of $-11.96 Million (operating CF $-11.96 Million minus capex $0.00) represents -2% of total liabilities ($6.57 Million). Also explore how fast is Kezar Life Sciences Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kezar Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Kezar Life Sciences Inc across 10 annual periods. Check Kezar Life Sciences Inc (KZR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kezar Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Kezar Life Sciences Inc. For the full company profile including market capitalisation, see Kezar Life Sciences Inc (KZR) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.87x | $-51.77 Million | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.18 Million | $-74.21 Million | $27.77 Million | ▼ -12.7% |
| 2023 | -2.37x | $-79.83 Million | $-81.64 Million | $33.66 Million | ▼ -23.0% |
| 2022 | -1.93x | $-57.27 Million | $-58.85 Million | $29.70 Million | ▲ +3.6% |
| 2021 | -2.00x | $-42.12 Million | $-42.44 Million | $21.06 Million | ▲ +40.9% |
| 2020 | -3.38x | $-36.76 Million | $-36.95 Million | $10.86 Million | ▼ -32.5% |
| 2019 | -2.55x | $-29.27 Million | $-29.88 Million | $11.47 Million | ▲ +23.6% |
| 2018 | -3.34x | $-19.67 Million | $-20.79 Million | $5.88 Million | ▼ -3360.0% |
| 2017 | -0.10x | $-7.72 Million | $-8.11 Million | $79.91 Million | ▲ +71.0% |
| 2016 | -0.33x | $-9.63 Million | $-9.76 Million | $28.85 Million | — |